Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Booster doses

Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients

Busyamas Chewaskulyong, Pattarapong Satjaritanun, Thanika Ketpueak, Thatthan Suksombooncharoen, Chaiyut Charoentum, Nuttaphoom Nuchpong, Apichat Tantraworasin

published 07 Nov 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Clinical features of and severity risk factors for COVID-19 in adults during the predominance of SARS-CoV-2 XBB variants in Okinawa, Japan

Shuhei Ideguchi, Kazuya Miyagi, Wakaki Kami, Daisuke Tasato, Futoshi Higa, Noriyuki Maeshiro, Shota Nagamine, Hideta Nakamura, Takeshi Kinjo, Masashi Nakamatsu, Shusaku Haranaga, Akihiro Tokushige, Shinichiro Ueda, Jiro Fujita, Kazuko Yamamoto

published 31 Oct 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Association of self-reported periodontal disease and inequities with long haul COVID-19

Sara Alhaffar, Sriha Yalamanchi, Anubhuti Shukla

published 10 Oct 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Seroprevalence of Bordetella pertussis infection in children 1–14 years old: Indonesia basic health research (Riskesdas) 2013 and 2018 data

Monica Dwi Hartanti, Novaria Sari Dewi Panjaitan, Sunarno Sunarno, Nathalia Ningrum, Armedy Ronny Hasugian, Rita Marleta Dewi, Sarwo Handayani, Masri Sembiring Maha, Firda Fairuza, Meiriani Sari, Dita Setiati, Christina Safira Whinie Lestari

published 30 Sep 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals: Case studies in the Indo-Pacific

Gizem Mayis Bilgin, Syarifah Liza Munira, Kamalini Lokuge, Kathryn Glass

published 30 Sep 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Examination of factors that impact mask or respirator purchase and usage during the COVID-19 pandemic

Nicole Bertges, Sachiyo Shearman, Satomi Imai, Jo Anne G. Balanay, Sinan Sousan

published 25 Sep 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Effect of vaccine dose intervals: Considering immunity levels, vaccine efficacy, and strain variants for disease control strategy

Samiran Ghosh, Malay Banerjee, Amit K. Chattopadhyay

published 19 Sep 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023

Chayanit Mahasing, Rapeepong Suphanchaimat, Pard Teekasap, Natthaprang Nittayasoot, Suphanat Wongsanuphat, Panithee Thammawijaya

published 17 Sep 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization

Rima Moghnieh, Wajdi Haddad, Nayla Jbeily, Salam El-Hassan, Shadi Eid, Hicham Baba, Marilyne Sily, Yara Saber, Dania Abdallah, Abdul Rahman Bizri, Mohamed H. Sayegh

published 13 Sep 2024

Loading metrics information...

Metrics unavailable. Please check back later.

COVID-19 vaccination uptake in remote areas—Evidence from a panel survey in Bangladesh

Lukas Rudolph, Vally Koubi, Jan Freihardt

published 09 Aug 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Factors associated with SARS-CoV-2 infection among people living with HIV: Data from the Balearic cohort (EVHIA)

Francisca Artigues Serra, Sophia Pinecki Socias, Francisco Javier Fanjul, Maria Peñaranda, Francisco Homar, Patricia Sorni, Julia Serra, Adelaida Rey, Lola Ventayol, Maria Dolores Macia, Maria Àngels Ribas, Melchor Riera

published 07 Aug 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago

Fabiola Moreno Echevarria, Mathew Caputo, Daniel Camp, Susheel Reddy, Chad J. Achenbach

published 05 Aug 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles

Jennifer Serwanga, Gerald Kevin Oluka, Claire Baine, Violet Ankunda, Jackson Sembera, Laban Kato, Joseph Ssebwana Katende, Geoffrey Odoch, Betty Oliver Auma, Ben Gombe, The COVID-19 Immunoprofiling Team , Monica Musenero, Pontiano Kaleebu

published 29 Jul 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Booster doses

You can change these options by clicking profile then "Alerts and Notifications"